Senescent cells: an emerging target for diseases of ageing

Childs, Bennett G., Gluscevic, Martina, Baker, Darren J., Laberge, Remi-Martin, Marquess, Dan, Dananberg, Jamie, van Deursen, Jan M.·2017·Nature Reviews Drug Discovery
DOI 10.1038/nrd.2017.116

Cites (216)

Items 201–217 of 217

  1. HMGA2 expression in white adipose tissue linking cellular senescence with diabetes
    Dominique Nadine Markowski, Helge Wilhelm Thies, Andrea Gottlieb, H. Wenk, Manfred Bernd Wischnewsky, Jörn Bullerdiek · 2013 · Genes & Nutrition
  2. Real‐time imaging of transcriptional activation in live cells reveals rapid up‐regulation of the cyclin‐dependent kinase inhibitor gene CDKN1A in replicative cellular senescence
    Utz Herbig, Wenyi Wei, Annie Dutriaux, Wendy A. Jobling, John M. Sedivy · 2003 · Aging Cell
  3. Decoy Receptor-2 Small Interfering RNA (siRNA) Strategy Employing Three Different siRNA Constructs in Combination Defeats Adenovirus-Transferred Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Resistance in Lung Cancer Cells
    Çiğdem Aydın, Ahter Dilşad Şanlioğlu, Bahri Karaçay, Gülay Özbilim, Levent Dertsiz, Ömer Özbudak, Cezmi A. Akdiş, Salih Şanlıoğlu · 2007 · Human Gene Therapy
  4. Shp2 signaling suppresses senescence in PyMT‐induced mammary gland cancer in mice
    Linxiang Lan, Jane D. Holland, Jingjing Qi, Stefanie Grosskopf, Regina Vogel, Balázs Győrffy, Annika Wulf‐Goldenberg, Walter Birchmeier · 2015 · The EMBO Journal
  5. Enhanced susceptibility of cyclin kinase inhibitor p21 knockout mice to high fat diet induced atherosclerosis
    Ashwani K. Khanna · 2009 · Journal of Biomedical Science
  6. PD‐1 signalling in CD4+ T cells restrains their clonal expansion to an immunogenic stimulus, but is not critically required for peptide‐induced tolerance
    Joanne Elizabeth Konkel, Friederike Frommer, Melanie D. Leech, Hideo Yagita∥, Ari Waisman, Stephen M. Anderton · 2010 · Immunology
  7. Requirement for pre-existing of p21 to prevent doxorubicin-induced apoptosis through inhibition of caspase-3 activation
    Juanjuan Tang, Chen‐Tian Shen, Yanjun Lu · 2006 · Molecular and Cellular Biochemistry
  8. Aberrant expression and function of death receptor-3 and death decoy receptor-3 in human cancer
    Zhicheng Ge, Andrew James Sanders, Lin Ye, Wen G. Jiang · 2011 · Experimental and Therapeutic Medicine
  9. Kinetics of In vitro ageing of mouse embryo fibroblasts
    Calliopi Karatza, Wilfred Donald Stein, Sydney Shall · 1984 · Journal of Cell Science
  10. Aberrant expression of decoy receptor 3 in human breast cancer: relevance to lymphangiogenesis
    Qiu-Wan Wu, Yahong Zheng, Donghan Chen, Xiaohong Li, Chuanhui Lu, Zhiming Zhang · 2014 · Journal of Surgical Research
  11. Longitudinal assessment of carotid atherosclerosis after Radiation Therapy using Computed Tomography: A case control Study
    Michele Anzidei, Jasjit S. Suri, Luca Saba, Roberto Sanfilippo, Giancarlo Laddeo, Roberto Montisci, Mario Piga, Giovanni Maria Argiolas, Eytan Raz · 2015 · European Radiology
  12. Down-regulation of DcR2 sensitizes androgen-dependent prostate cancer LNCaP cells to TRAIL-induced apoptosis
    David Vindrieux, Marie Réveiller, Jacqueline Chantepie, Sadok Yakoub, Catherine Deschildre, A. Ruffion, MARIAN DEVONEC, Mohamed Benahmed, Renée Grataroli · 2011 · Cancer Cell International
  13. SHP2: a new target for pro‐senescence cancer therapies
    Serrano, Manuel · 2015 · The EMBO Journal
  14. Cellular senescence and aging
    C‐K Yeh · 2016 · Oral Diseases
  15. The role of Clara cell senescence in the pathogenesis of COPD
    Amir Bar‐Shai, Adi Sagiv, Ronen Alon, Valery Krizhanovsky · 2014 · European Respiratory Journal
  16. Erratum To: Shp2 signaling suppresses senescence in PyMT‐induced mammary gland cancer in mice
    Linxiang Lan, Jane D. Holland, Jingjing Qi, Stefanie Grosskopf, Jörg Rademann, Regina Vogel, Balázs Győrffy, Annika Wulf‐Goldenberg, Walter Birchmeier · 2015 · The EMBO Journal
  17. Cellular senescence and cancer
    1999